国际生殖健康/计划生育 ›› 2015, Vol. 34 ›› Issue (4): 283-285.

• 论著 • 上一篇    下一篇

控制性促排卵周期移植第6天血清孕酮/雌二醇水平与IVF/ICSI-ET临床结局的关系

项云改,万利静,宋玉霞,楚喜英,谭丽   

  1. 450014 郑州大学第二附属医院生殖中心
  • 收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:2015-07-15 发布日期:2015-07-15
  • 通讯作者: 谭丽

Level of Serum P/E2 on Day 6 after Embryo Transfer of COH and Clinical Outcomes of IVF/ICSI-ET

XIANG Yun-gai,WAN Li-jing,SONG Yu-xia,CHU Xi-ying,TAN Li   

  1. Reproductive Center,The Second Affiliated Hospital of Zhengzhou University,Zhengzhou 450014,China
  • Received:1900-01-01 Revised:1900-01-01 Published:2015-07-15 Online:2015-07-15
  • Contact: TAN Li

摘要: 目的:探讨控制性促排卵(COH)周期中移植第6天血清孕酮/雌二醇(P/E2)水平对体外受精/卵胞浆内单精子显微注射-胚胎移植(IVF/ICSI-ET)临床结局的预测价值。方法:回顾性分析544个COH的IVF-ET周期,根据受试者工作特征曲线(ROC)将移植第6天P/E2比值分为2组:P/E2水平<114.5(A组)与P/E2水平≥114.5(B组),分析2组间一般临床特征、胚胎种植率和临床妊娠率的差异。结果:A、B组间的子宫内膜厚度、促性腺激素(Gn)用量、Gn时间及移植胚胎数等一般资料间差异无统计学意义(P>0.05),但A组胚胎种植率和临床妊娠率均高于B组,差异有统计学意义(P<0.05)。结论:COH周期移植第6天血清P/E2水平<114.5妊娠结局较好,对IVF-ET临床结局有一定预测价值。

关键词: 超排卵, 胚胎移植, 孕激素, 雌二醇, 妊娠结局

Abstract: Objective: To explore the relationship between the level of serum P/E2 on the day 6 after embryo transfer of cotrolled ovarian hyperstimulation and the clinical outcomes of IVF/ICSI-ET. Methods:A total of 544 cycles of IVF-ET were divided into two groups by the level of P/E2 on the day 6 after ET: group A (P/E2<114.5) and group B(P/E2≥114.5). The clinical data, implantation rate and clinical pregnancy rate were compared between two groups. Results:There were not significant differences between two groups in the endometrial thickness, total dose of gonadotropin, duration of gonadotropin and number of ET (P>0.05). However, the implantation rate and clinical pregnancy rate in the group A were significantly higher than those in the group B (P<0.05). Conclusions:The clinical outcomes will be better if the level of serum P/E2 on the day 6 after ET was lower than 114.5, suggesting that the level of serum P/E2 on the day 6 is a useful parameter predicting clinical outcomes of IVF.

Key words: Superovulation, Embryo transfer, Progestins, Estradiol, Pregnancy outcome